Patent Litigation in Ireland: 6 Critical Facts

If a competitor is infringing your patent in Ireland — or you have been accused of infringing one — the forum, the tactics and the timeline are not what you may expect from London or the Unified Patent Court. Patent litigation in Ireland runs through a single, fast-moving commercial division of the High Court in Dublin, where infringement and validity are decided together and injunctions turn on a test the Supreme Court recently reshaped. Here are six things every patent owner and accused infringer should understand before a dispute escalates.

Patent Litigation in Ireland Starts in the High Court

Patent infringement and revocation actions under the Patents Act 1992 must be brought in the High Court. There is no specialist patents court and no regional patents list — Dublin hears the lot. This concentrates expertise but also means cases compete for time with the rest of the High Court’s commercial docket.

The practical answer is the Commercial List, described next. A short-term patent can also be enforced in the Circuit Court, but the serious, high-value disputes — pharma, medtech, telecoms — almost always sit in the High Court.

The Commercial List: Ireland’s Fast Track

Either party can apply to transfer a patent action into the Commercial List of the High Court, governed by Order 63A of the Rules of the Superior Courts. The Commercial List is Ireland’s answer to England’s Patents Court: active judicial case management, tight timetables and judges who deal with complex commercial disputes day in, day out.

Most commercial proceedings need a value of at least €1 million to qualify — but proceedings under the Patents Act 1992 are a named category that can be admitted regardless of monetary value. That is why serious Irish patent cases almost invariably end up on the Commercial List, where a case that might otherwise drift can reach trial in a matter of months rather than years.

Admission is not automatic. The judge in charge of the list controls entry and will expect the parties to be ready to work to a disciplined timetable — pleadings, discovery, expert reports and a fixed trial date, all compressed. For a patentee that wants speed, or an accused infringer that wants certainty, the Commercial List is usually where you want to be, and applying early signals that you are serious about getting to trial rather than using the litigation as leverage.

Validity and Infringement Are Decided Together

Ireland does not bifurcate. Unlike the German system — where a separate court rules on validity — the same Irish judge hears infringement and validity in one proceeding. An accused infringer typically defends by denying infringement and counterclaiming that the patent is invalid.

Revocation can be sought by any person. Under the Patents Act 1992 an application to revoke a patent can be made to the High Court or, in defined circumstances, to the Controller of Intellectual Property. Common grounds are lack of novelty, obviousness, insufficiency and added matter — the same attacks that a strong invalidity search is built to support.

The single-forum model has tactical consequences. An infringement claimant has to be confident the patent will survive the inevitable validity counterclaim, because a finding of invalidity does not just defeat the claim — it revokes the patent against the world. Defendants, conversely, often lead with invalidity, treating the prior art as their strongest card. There is no window in which infringement is decided while validity is parked, so both cases are prepared in parallel from day one.

Because validity is live in almost every case, the quality of the prior-art record often decides the outcome. Our Dublin litigation-search team assembles that record on both sides of a dispute.

Injunctions: The Reshaped Campus Oil Test

Interlocutory (preliminary) injunctions are the pressure point in Irish patent disputes. The classic test from Campus Oil asks whether there is a serious issue to be tried, whether damages are an adequate remedy, and where the balance of convenience lies.

The Supreme Court recalibrated that test for patent cases in Merck Sharp & Dohme v Clonmel Healthcare [2019] IESC 65, directing courts to weigh the adequacy of damages as part of a flexible overall assessment of the least risk of injustice rather than as a rigid gate. For a patentee facing a generic launch, an interlocutory injunction can be the whole ballgame — and the Clonmel framework makes the outcome genuinely fact-sensitive.

Two practical points follow. First, the party seeking an injunction will usually have to give an undertaking as to damages — a promise to compensate the other side if the injunction is later shown to have been wrongly granted — and in a pharmaceutical case that exposure can be enormous. Second, because the Clonmel balancing is holistic, the strength of each side’s case on validity and infringement feeds directly into the court’s assessment, which is yet another reason the prior-art record is prepared early and thoroughly.

Remedies, Timelines and Costs

A successful patentee in Ireland can obtain a wide range of remedies:

• A permanent injunction restraining further infringement.
• Damages or, at the claimant’s election, an account of the infringer’s profits.
• Delivery up or destruction of infringing goods.
• A declaration of infringement and, in appropriate cases, publication of the judgment.

On the Commercial List a case can move from issue to trial within roughly 12 to 24 months, faster than many European venues. Ireland follows the loser-pays principle, so the unsuccessful party will usually be ordered to pay a substantial portion of the winner’s costs — a real factor in settlement strategy. Appeals go to the Court of Appeal, and in cases of general public importance, onward to the Supreme Court.

Why the Unified Patent Court Does Not Apply

This is the fact most often misunderstood. Ireland signed the Unified Patent Court Agreement in 2013, but ratification requires a constitutional referendum. A referendum planned for June 2024 was deferred, and no new date has been set. Until that changes, there is no Irish division of the UPC, and a Unitary Patent does not extend to Ireland at all.

The consequence is concrete: to have an enforceable right in Ireland you still need either a national Irish patent or a classic European patent validated here — the routes we explain in how to file a patent in Ireland. Enforcement of that right happens in Dublin, under Irish law, before an Irish judge. For a full picture of protecting and defending rights across the jurisdiction, start at our Ireland hub.

Build a Winning Irish Patent Case

Whether you are enforcing a patent or defending against one in Ireland, the prior-art record and invalidity position usually decide it. PerspireIP delivers litigation-grade invalidity and infringement searches that stand up in the Commercial List. Contact our team to discuss your Irish dispute.

Frequently Asked Questions